Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Node; Prostate × Genitourinary × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4356 Urinary Bladder Neoplasms 1066 Carcinoma, Renal Cell 1029 Kidney Neoplasms 561 Breast Neoplasms 447 Neoplasms 398 Carcinoma, Transitional Cell 291 Neoplasm Metastasis 247 Lung Neoplasms 240 Testicular Neoplasms 199 Melanoma 192 Colorectal Neoplasms 191 Ovarian Neoplasms 160 Carcinoma, Non-Small-Cell Lung 147 Sarcoma 133 Non-Muscle Invasive Bladder Neoplasms 133 Pancreatic Neoplasms 122 Colonic Neoplasms 121 Head and Neck Neoplasms 114 Uterine Cervical Neoplasms 113 Wilms Tumor 106 Recurrence 103 Motor Activity 99 Stomach Neoplasms 89 Urologic Neoplasms 87 Neuroblastoma 87 Multiple Myeloma 83 Carcinoma, Hepatocellular 78 Disease 77 Esophageal Neoplasms 76

Interventions

durvalumab 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03795207 2026-03-31

POSTCARD

Institut Cancerologie de l'Ouest

Phase 2 Active not recruiting

Node; Prostate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡